Selected funding as PI only:

2025: CIHR – Randomized Controlled Trials – Human Development Child and Youth Health
The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial
Nominated P.A. Skeith L, Principal Applicants: Darine El-Chaâr, et al. (400,000$)

2025: CIHR – Reproduction, Maternal, Child and Youth Health
Impact of placental microplastic accumulation on pregnancy and fetal health.
Nominated PA Bainbridge SA, P Applicants: Darine El-Chaâr, et al. (1,346,000$)

2024 - 2029: CIHR – Child and Youth Health
Decoding the Dynamic Interplay of Gestational Physician Activity, Microbiome, and Metabolome in Maternal-Fetal Wellbeing
Applicants: Adamo K, Darine El-Chaâr, et al (745,875$)

2024: CIHR – Respiratory Assessment among Pregnant Individuals for Detecting febrile infections in Ottawa, Ontario
Principal Investigator: Darine El-Chaâr (100,000$)

2024: CIHR – Infectious and Congenital Syphilis in Canada: Implementation and Intervention Research.
Towards the eradication of congenital syphilis in Canada
Principal Investigator: Money DM, Darine El-Chaâr et al (249,543$)

2024: CIHR – Institute of Human Development, Child and Youth Health (IHDCYH)
Infant and child health outcomes following SARS-CoV-2 infection in pregnancy
Principal Investigator: Darine El-Chaâr, Hawken S, Brophy CJ. (175,000$)

2024: CIHR – Piloting the EAGER trial: Expectant management versus induction at 38 weeks among individuals with GEstational diabetes mellitus. Randomized controlled trial
Principal Investigator: Walker MC, Darine El-Chaâr, Asztalos EV, Fergusson DA, Feig DS. (569,926$)

2023: CIHR – Institute of Human Development, Child and Youth Health (IHDCYH) Additional Funding.
Infant and child health outcomes following SARS-CoV-2 infection in pregnancy
Principal Investigator: Darine El-Chaâr, Brophy J, Hawken S. (100,000$)

2022 - 2024: Public Health Agency of Canada (PHAC). A Network to Improve Cardiovascular Disease Prevention and Care for Women
Principal Investigator: Mullen KA, Coutinho T. Co-Investigator: Darine El-Chaâr (1,200,000$)

2021:  CIHR–Emerging COVID-19 Research Gaps and Priorities Funding Opportunity
Pregnant and Lactating Individuals & Newborns COVID-19 Vaccination Study? 
Principal Investigator: Darine El-Chaâr  (500,000$)     

2020:  CIHR - COVID-19 Rapid Research – Clinical Management & Health System Interventions. 
Research Assessing the impact of COVID-19 in pregnancy, fetal and newborn health  
Principal Investigator: Darine El-Chaâr  (795, 559$)         

2019 - 2024: CIHR – Neurodevelopment.  Cannabis Research in Priority Areas.  Research Pan-Canadian network to investigate cannabis use in pregnancy and neurodevelopmental outcomes in children. 
Principal Investigator: Daniel Corsi, Darine El-Chaâr (Co-Applicant) (299,978$)

2018 - 2019: CIHR Catalyst Grant: Population Health Intervention Research  on Legalization of Cannabis.  Research Influence of cannabis exposure in pregnancy on offspring perinatal and childhood health outcomes: a population-based birth cohort.  
Principal Investigator: Darine El-Chaâr, Daniel Corsi (94,691$)

2016 - 2021: CIHR – Preterm Birth Network – Team Grant: Research Improving Outcomes for Preterm Infants and their Families: A Canadian Collaborative Network. 
TOH Co-Principal Investigator:  Darine El-Chaâr (4,250,000$)   

2016 - 2022: CIHR – Foundation Scheme: 
An epidemiologic research program to improve maternal and child health. 
Principal applicants: Walker M, Wen SW.  Co-applicants: Darine El-Chaâr (9,876,973$) 

2013 - 2014: Mount Sinai Hospital Grant: 
Assessment of a high-fidelity simulator-based curriculum for teaching Chorionic villus sampling (CVS)
Principal Investigator (10,000$) 

2011 - 2012: Canadian Foundation for Women’s Health / W. Garfield Weston Foundation Award: 
The Impact of Maternal Body Mass Index on Postpartum Obstetrical Outcomes 
Principal Investigator (17,000$)